SCIEX launches the Topaz™ LC-MS/MS System for Clinical Diagnostics in Europe

SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, will be showcasing the SCIEX Topaz™ System for Clinical Diagnostics at the 4th Annual European Congress & Exhibition of the Association for Mass Spectrometry: Application to the Clinical Lab (MSACL EU 2017) in Salzburg, Austria on September 10-14. This fully integrated LC-MS/MS system for clinical diagnostics will be showcased in the SCIEX booth (#12-13) and live software demonstrations will be offered throughout the exhibition. The Topaz System is designed specifically to meet the unique needs of the clinical diagnostic lab, lowering the barriers to adoption of LC-MS/MS and making it accessible to the entire clinical lab staff.

The Topaz System offers unique flexibility; with both an open system designed for lab-developed tests (LDTs) and for the capability for running locked, SCIEX pre-developed assays kits. The easy-to-use Topaz System enables clinical labs to expand their testing services and bring previously outsourced tests in-house, providing opportunities for cost savings along with gold-standard accuracy, in less time, with less complexity - all for the benefit of supporting quality patient care. The system’s innovative ClearCore™ MD software simplifies and streamlines workflows and method development, and incorporates features that enhance usability to help new users build proficiency quickly. 

“SCIEX set out with the goal of making mass spectrometry simple for clinical labs, and the outcome is the integrated LC-MS-based IVD system that is open by design and closed when you need it,” said Dr. Aaron Hudson, Sr. Director and GM of SCIEX Diagnostics. “The innovative ClearCore MD software simplifies and streamlines workflows and method development, bringing the power of SCIEX LC-MS technology to the hands of the routine user.”